Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Screenshot: Axios Events

Housing and Urban Development Secretary Ben Carson says "this is not necessarily the time to take everything slowly" when it comes to the Trump administration's approach to getting vaccines and treatments to the public.

Why it matters: Carson's comments, made Wednesday during an Axios virtual event, came days after the Food and Drug Administration announced an emergency use authorization (EUA) for treating the coronavirus with convalescent plasma. President Trump accused the agency of slow-walking the development and approval of vaccines and therapeutics to hurt him politically.

What Carson's saying: "That is the time to maximize your resources—not to skips steps—but to move expeditiously. And if you have something that you know is safe or relatively safe and you have evidence that it's very effective, it would behoove you to move forward with testing."

  • "Rather than just leave that process languishing, I think what the president is saying is 'Look folks, this is not normal times. We need to move forward. We can't just sit and lollygag at a time like that.'"
  • "You have to recognize we want to open the economy back up. We want people to stop being afraid of everything. And that will happen when we have some effective therapies, when we have an effective vaccine. So we certainly don't want to impede or slow down that process. We only want to speed that process up."

Go deeper: What it's like to give convalescent plasma

Watch the event.

Go deeper

Updated Dec 4, 2020 - Health

Fauci apologizes for criticizing U.K. regulators over Pfizer vaccine approval

Photo: Jabin Botsford/The Washington Post via Getty Images

Anthony Fauci, the U.S. government's top infectious-disease expert, on Thursday walked back his earlier comments criticizing British regulators over their recent approval the Pfizer-BioNTech COVID-19 vaccine.

What he's saying: "I have a great deal of confidence in what the U.K. does both scientifically and from a regulator standpoint," Dr Fauci told the BBC on Thursday after saying earlier in the day that U.K. regulators "rushed" their approval of the vaccine.

Dec 3, 2020 - Health

WSJ: Pfizer expects to ship half as many COVID vaccines as planned in 2020

A Pfizer factory in Puurs, Belgiam on Dec. 3. Photo: Kenzo Tribouillard/AFP via Getty Images

Pfizer and BioNTech have halved their original estimates for how many coronavirus vaccines would be shipped globally by the end of this year, citing supply-chain issues, the Wall Street Journal first reported.

Why it matters: The U.K. government has ordered 40 million doses of Pfizer-BioNTech's vaccine — enough to inoculate some 20 million people. The companies now expect to ship 50 million vaccines by the end of 2020, per WSJ.

Updated Dec 4, 2020 - Politics & Policy

Highlights from Biden and Harris' first joint interview since the election

Joe Biden. Photo: Mark Makela/Gettu Images

President-elect Joe Biden and Vice President-elect Kamala Harris sat down with CNN on Thursday for their first joint interview since the election.

The big picture: In the hour-long segment, the twosome laid out plans for responding to the pandemic, jump-starting the economy and managing the transition of power, among other priorities.